Interest in psychedelic therapies for adults is rapidly growing, with substances like 3,4-methylenedioxymethamphetamine for posttraumatic stress disorder, psilocybin for treatment-resistant depression, and lysergic acid diethylamide for generalized anxiety disorder showing promise. However, research on these therapies in children and adolescents is limited, with no recent trials. Despite this...
Emerging psychedelic research highlights the therapeutic potential and broader positive psychological transformation of psychedelic-assisted therapy. While naturalistic studies support these outcomes, gaps remain in understanding the specific nature of perceived benefits and in the availability of validated instruments to assess them. This study aimed to develop and validate the Perceived...
Objective: Previous studies claim a healing effect on psychological and medical symptoms beyond the biopsychosocial construct of medicine to include a “spiritual” aspect with added experience of wholeness and well-being. A recommendation for the development of a human ontological model for research of this spiritual domain has been suggested. The objective of this study was to test feasibility...
After a dormant period of over 30 years, research into the use of traditional as well as some non-traditional psychedelics has enjoyed a resurgence around the world. This paper investigates the biological and psychological operations of psychedelics, comparing its, merits relative to other mental health care approaches. This form of therapy is unique in that it aims to heal, rather than merely...
This study aimed to characterize attitudes and identify gaps in trainee knowledge and education that may impact the field's readiness for the reemergence of psychedelic use in psychiatry. A two-part survey was sent out targeting medical and allied professional trainees who may interact with patients using or planning to use psychedelics therapeutically. Collected data for part one characterized...
Despite decades of neuroscience research and significant investment in addiction neuroimaging, clinical outcomes for individuals with substance use and behavioural addictions remain poor. Only 1.8% of people with substance use disorders receive effective treatment, highlighting a major disconnect between mechanistic understanding and clinical utility. This paper calls for a reorientation of...
The use of psychedelics has recently gained increased interest among bioethicists, as the articles published in this journal attest. Some of the recent scholarship suggests that psychedelic experie...
The resurgence of psychedelic research has brought with it unique ethical considerations, including the role of personal psychedelic experience among facilitators. Some have argued that personal ps...